DCF — JACOBI MEDICAL CENTER
Enterprise Value: $-2.9B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-2.9B
Enterprise Value
$-890.8M
PV of Cash Flows
$-2.0B
PV of Terminal Value
$-3.2B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.2B | $-191.2M | -16.0% | $-240.8M | $-218.9M |
| Year 2 | $1.2B | $-184.8M | -15.0% | $-236.0M | $-195.0M |
| Year 3 | $1.2B | $-177.9M | -14.0% | $-230.6M | $-173.2M |
| Year 4 | $1.3B | $-176.8M | -14.0% | $-231.1M | $-157.8M |
| Year 5 | $1.3B | $-178.8M | -14.0% | $-234.7M | $-145.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-2.9B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.1B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1679547550708462
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5